Blue Light‐Mediated Nitric Oxide‐Releasing Formulation for the Multimodal Treatment of Acne Vulgaris
- 26 June 2026
- journal article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (29) , e71395
Abstract
The topical treatment of acne vulgaris by a single therapeutic is difficult given the multifaceted causes of the disease. Treatment with photo‐responsive nitric oxide (NO) donors and light represents an attractive alternative to conventional therapeutics due to the potential for multimodal therapeutic action against downstream acne processes. Herein, a topical hyaluronic acid (HA) formulation was developed to facilitate localized NO delivery from mesoporous silica nanoparticle (MSN) NO donors upon blue light exposure, while simultaneously providing anti‐inflammatory activity. The NO release was tunable (0.09–0.51 µmol NO mg −1 ) depending on wavelength, with shorter wavelengths and greater irradiances providing more efficient photolytic liberation. Antibacterial activity and cytocompatibility were directly modulated by photolytic NO release and payload, where NO was determined to be the primary antibacterial agent and large, initial NO bursts led to preservation of cell viability. Incorporation of the MSN‐based NO donors into an HA formulation afforded additional metabolic and immunomodulatory behavior in vitro, demonstrating potential to decrease sebum production and inflammation in acne vulgaris. Blue light‐mediated NO release from the HA formulation presents a multifunctional therapeutic platform that addresses key contributing downstream factors of acne.Keywords
Funding Information
- National Institutes of Health (DE032060)
- National Science Foundation (ECCS‐2025064)
This publication has 73 references indexed in Scilit:
- Nitric oxide-releasing thiolated starch nanoparticles embedded in gelatin sponges for wound dressing applicationsInternational Journal of Biological Macromolecules, 2024
- Retinoid nanoparticulates: Approachable gateway for acne treatmentHealth Sciences Review, 2022
- Management of Acne VulgarisJAMA, 2021
- Antimicrobial blue light: A ‘Magic Bullet’ for the 21st century and beyond?Advanced Drug Delivery Reviews, 2021
- Targeted clindamycin delivery to pilosebaceous units by chitosan or hyaluronic acid nanoparticles for improved topical treatment of acne vulgarisCarbohydrate Polymers, 2021
- Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota CharacteristicsJAMA Dermatology, 2019
- Nitric Oxide–Releasing Macromolecular Scaffolds for Antibacterial ApplicationsAdvanced Healthcare Materials, 2018
- Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?Drug Resistance Updates, 2012
- Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticlesBiomaterials, 2009
- Acne: InflammationClinics in Dermatology, 2004